HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 26, Nos. 09 & 10, September & October 2022 – Toxins and Medicines – Two Sides of the Same Coin       » Utilising Metal Nanoparticles as Plant Growth Regulators to Improve Crop Yield       » Remedy or Poison? How Microplastics Influence Copper Ion Toxicity in Aquatic Plants       » Synthesising Schiff Base Antimicrobial Copper Complexes With Unprecedented Speed       » Enhancing the Understanding of Past Infections With Machine Learning       » Mini, Cellular Bioweapons: Understanding the Structure and Mechanism of Stinging in Sea Anemone Nematocysts       » Converting Dead Spiders Into Gripping Tools
Vol 26, Nos. 09 & 10, September & October 2022   |   Issue PDF view/purchase
EYE ON CHINA
Predicting Radiotherapy Treatment Response With This New Radiomic Model
This constructed model can help guide clinicians direct personalised therapy strategies in a more comprehensible manner.

Radiometrics refers to the use of high-throughput radiological features from medical images to guide clinical decision-making. These obtained radiological features can reflect certain biological information of tumours that cannot be directly obtained by traditional image interpretation. Therefore, machine learning-based approaches that use in-depth data mining will allow us to gain more knowledge about tumour heterogeneity. However, there has not yet been a model to accurately predict the efficacy of radiotherapy in brain cancer patients in clinical practice.

Recently, a research team led by Professor Li Hai and Wang Hongzhi from the Hefei Institutes of Physical Sciences of the Chinese Academy of Sciences (CAS) recently constructed an interpretable radiomic model to predict radiotherapy treatment response in patients with brain tumours.

From 228 patients, 960 features were extracted from the magnetic resonance imaging (MRI) images of each tumour before radiotherapy. Then, they used machine learning to model the radiation. Finally, Shapley Additive exPlanations (SHAP) was used to assess the treatment response of whole-brain radiotherapy.

According to Wang Yixin, the model performed well and the prediction results of the external validation group also show that the model has generalisation to a certain extent.

At the same time, the SHAP method can achieve interpretability and visualisation of the model, avoiding the “black box” effect of traditional machine learning algorithm. This means that the team’s constructed radiomic model with the SHAP method is better able to aid clinicians in directing personalised whole-brain radiotherapy strategies in a more comprehensible manner.


Source: Wang et al. (2022). The radiomic-clinical model using the SHAP method for assessing the treatment response of whole-brain radiotherapy: a multicentric study. European Radiology, 1-11.

FORTHCOMING ISSUE  
What Has Covid Ever Done for Us?
NEWS CRUNCH  
news 2022 PDA Aseptic Processing of Biopharmaceuticals Conference
news Thailand LAB INTERNATIONAL, Bio Asia Pacific, and FutureCHEM INTERNATIONAL are ready to offer the Science and Technology Industry complete solutions this September!
news Better together: registration opens for Vitafoods Asia 2022 co-located with Fi Asia in October
news 2022 PDA Pharmaceutical Manufacturing & Quality Conference
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   [email protected] or Ms Carmen Chan
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   [email protected]
Copyright© 2022 World Scientific Publishing Co Pte Ltd  •  Privacy Policy